Dr Reddy’s to buy Haleon’s nicotine replacement therapy portfolio outside US for £500 mn

Dr. Reddy's Laboratories SA will acquire the share capital of Haleon plc's arm Northstar Switzerland.The payment comprises an upfront cash payment of £458 million and performance-based contingent payments of up to £42 million.
Read The Rest at :